Did you miss Thermo Fisher Scientific at CPHI Barcelona? You can still connect with our team post-show.
The Challenge: A new United States-based biopharma working on its first cell therapy-based treatment had expanded the scope of their trial and extended its patient pool to include a patient in Beijing, China.
Download this case study to learn how they addressed the challenges of: